Initial molecular response at 3 months may predict both response and event-free survival at 24 months in imatinib-resistant or -intolerant patients with philadelphia chromosome-positive chronic myeloid leukemia in chronic phase treated with nilotinib

Saved in:
Bibliographic Details
Main Author: Branford, Susan (Author)
Other Authors: Müller, Martin Christian (Other)
Format: Article (Journal)
Language:English
Published: 2012
In: Journal of clinical oncology. [Englische Ausgabe]
Year: 2012, Volume: 30, Issue: 35, Pages: 4323-4329
ISSN:0732-183X
Online Access: Get full text
Author Notes:Branford, Susan ... Mueller, Martin C.